Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking

Background/Aims: Glioblastoma multiforme (GBM) is the most devastating and widespread primary central nervous system tumour in adults, with poor survival rate and high mortality rates. Existing treatments do not provide substantial benefits to patients; therefore, novel treatment strategies are requ...

Full description

Bibliographic Details
Main Authors: Boxian Zhao, Chen Shen, Zhixing Zheng, Xiaoxiong Wang, Wenyang Zhao, Xin Chen, Fei Peng, Linmeng Xue, Mengting Shu, Xu Hou, Kaikai Wang, Chen Zhong, Jingxian Sun, Jinzhao Wan, Shiguang Zhao
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/495646
_version_ 1819070007084056576
author Boxian Zhao
Chen Shen
Zhixing Zheng
Xiaoxiong Wang
Wenyang Zhao
Xin Chen
Fei Peng
Linmeng Xue
Mengting Shu
Xu Hou
Kaikai Wang
Chen Zhong
Jingxian Sun
Jinzhao Wan
Shiguang Zhao
author_facet Boxian Zhao
Chen Shen
Zhixing Zheng
Xiaoxiong Wang
Wenyang Zhao
Xin Chen
Fei Peng
Linmeng Xue
Mengting Shu
Xu Hou
Kaikai Wang
Chen Zhong
Jingxian Sun
Jinzhao Wan
Shiguang Zhao
author_sort Boxian Zhao
collection DOAJ
description Background/Aims: Glioblastoma multiforme (GBM) is the most devastating and widespread primary central nervous system tumour in adults, with poor survival rate and high mortality rates. Existing treatments do not provide substantial benefits to patients; therefore, novel treatment strategies are required. Peiminine, a natural bioactive compound extracted from the traditional Chinese medicine Fritillaria thunbergii, has many pharmacological effects, especially anticancer activities. However, its anticancer effects on GBM and the underlying mechanism have not been demonstrated. This study was conducted to investigate the potential antitumour effects of peiminine in human GBM cells and to explore the related molecular signalling mechanisms in vitro and in vivo Methods: Cell viability and proliferation were detected with MTT and colony formation assays. Morphological changes associated with autophagy were assessed by transmission electron microscopy (TEM). The cell cycle rate was measured by flow cytometry. To detect changes in related genes and signalling pathways in vitro and in vivo, RNA-seq, Western blotting and immunohistochemical analyses were employed. Results: Peiminine significantly inhibited the proliferation and colony formation of GBM cells and resulted in changes in many tumour-related genes and transcriptional products. The potential anti-GBM role of peiminine might involve cell cycle arrest and autophagic flux blocking via changes in expression of the cyclin D1/CDK network, p62 and LC3. Changes in Changes in flow cytometry results and TEM findings were also observed. Molecular alterations included downregulation of the expression of not only phospho-Akt and phospho-GSK3β but also phospho-AMPK and phospho-ULK1. Furthermore, overexpression of AKT and inhibition of AKT reversed and augmented peiminine-induced cell cycle arrest in GBM cells, respectively. The cellular activation of AMPK reversed the changes in the levels of protein markers of autophagic flux. These results demonstrated that peiminine mediates cell cycle arrest by suppressing AktGSk3β signalling and blocks autophagic flux by depressing AMPK-ULK1 signalling in GBM cells. Finally, peiminine inhibited the growth of U251 gliomas in vivo. Conclusion: Peiminine inhibits glioblastoma in vitro and in vivo via arresting the cell cycle and blocking autophagic flux, suggesting new avenues for GBM therapy.
first_indexed 2024-12-21T16:59:05Z
format Article
id doaj.art-2cd6c464acf245e7a2c7565e560de860
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-21T16:59:05Z
publishDate 2018-11-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-2cd6c464acf245e7a2c7565e560de8602022-12-21T18:56:41ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-11-015141566158310.1159/000495646495646Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux BlockingBoxian ZhaoChen ShenZhixing ZhengXiaoxiong WangWenyang ZhaoXin ChenFei PengLinmeng XueMengting ShuXu HouKaikai WangChen ZhongJingxian SunJinzhao WanShiguang ZhaoBackground/Aims: Glioblastoma multiforme (GBM) is the most devastating and widespread primary central nervous system tumour in adults, with poor survival rate and high mortality rates. Existing treatments do not provide substantial benefits to patients; therefore, novel treatment strategies are required. Peiminine, a natural bioactive compound extracted from the traditional Chinese medicine Fritillaria thunbergii, has many pharmacological effects, especially anticancer activities. However, its anticancer effects on GBM and the underlying mechanism have not been demonstrated. This study was conducted to investigate the potential antitumour effects of peiminine in human GBM cells and to explore the related molecular signalling mechanisms in vitro and in vivo Methods: Cell viability and proliferation were detected with MTT and colony formation assays. Morphological changes associated with autophagy were assessed by transmission electron microscopy (TEM). The cell cycle rate was measured by flow cytometry. To detect changes in related genes and signalling pathways in vitro and in vivo, RNA-seq, Western blotting and immunohistochemical analyses were employed. Results: Peiminine significantly inhibited the proliferation and colony formation of GBM cells and resulted in changes in many tumour-related genes and transcriptional products. The potential anti-GBM role of peiminine might involve cell cycle arrest and autophagic flux blocking via changes in expression of the cyclin D1/CDK network, p62 and LC3. Changes in Changes in flow cytometry results and TEM findings were also observed. Molecular alterations included downregulation of the expression of not only phospho-Akt and phospho-GSK3β but also phospho-AMPK and phospho-ULK1. Furthermore, overexpression of AKT and inhibition of AKT reversed and augmented peiminine-induced cell cycle arrest in GBM cells, respectively. The cellular activation of AMPK reversed the changes in the levels of protein markers of autophagic flux. These results demonstrated that peiminine mediates cell cycle arrest by suppressing AktGSk3β signalling and blocks autophagic flux by depressing AMPK-ULK1 signalling in GBM cells. Finally, peiminine inhibited the growth of U251 gliomas in vivo. Conclusion: Peiminine inhibits glioblastoma in vitro and in vivo via arresting the cell cycle and blocking autophagic flux, suggesting new avenues for GBM therapy.https://www.karger.com/Article/FullText/495646PeiminineGBMCell cycleAutophagyAKT-GSK3βAMPK-ULK1
spellingShingle Boxian Zhao
Chen Shen
Zhixing Zheng
Xiaoxiong Wang
Wenyang Zhao
Xin Chen
Fei Peng
Linmeng Xue
Mengting Shu
Xu Hou
Kaikai Wang
Chen Zhong
Jingxian Sun
Jinzhao Wan
Shiguang Zhao
Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
Cellular Physiology and Biochemistry
Peiminine
GBM
Cell cycle
Autophagy
AKT-GSK3β
AMPK-ULK1
title Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
title_full Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
title_fullStr Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
title_full_unstemmed Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
title_short Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking
title_sort peiminine inhibits glioblastoma in vitro and in vivo through cell cycle arrest and autophagic flux blocking
topic Peiminine
GBM
Cell cycle
Autophagy
AKT-GSK3β
AMPK-ULK1
url https://www.karger.com/Article/FullText/495646
work_keys_str_mv AT boxianzhao peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT chenshen peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT zhixingzheng peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT xiaoxiongwang peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT wenyangzhao peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT xinchen peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT feipeng peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT linmengxue peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT mengtingshu peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT xuhou peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT kaikaiwang peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT chenzhong peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT jingxiansun peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT jinzhaowan peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking
AT shiguangzhao peiminineinhibitsglioblastomainvitroandinvivothroughcellcyclearrestandautophagicfluxblocking